CABG boosts outcomes in diabetes plus multivessel CAD

11/4/2012 | Healio

Data on 1,900 patients with diabetes and multivessel coronary artery disease showed those who underwent coronary artery bypass grafting had lower rates of all-cause mortality, nonfatal myocardial infarction or nonfatal stroke at five years compared with those who had percutaneous coronary intervention with a drug-eluting stent. Lower rates of cardiovascular and cerebrovascular events were also seen in the CABG group, researchers said. The results were presented at the American Heart Association meeting.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA